All Stories

  1. Association of the Triglyceride–Glucose Index with Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis
  2. Wearable Devices for Quantifying Atrial Fibrillation Burden: A Systematic Review and Bayesian Meta-Analysis
  3. Cryoballoon Pulmonary Vein Isolation in Obese Patients with Atrial Fibrillation Compared to Non-Obese Counterparts: A Meta-Analysis
  4. Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis
  5. Efficacy, Safety and Feasibility of Superior Vena Cava Isolation in Patients Undergoing Atrial Fibrillation Catheter Ablation: An Up-to-Date Review
  6. Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review
  7. A call for shorter blanking period, time to get off the ground
  8. Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review
  9. Left Distal Radial Artery Access for Coronary Angiography and Interventions: A 12-Month All-Comers Study
  10. Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis
  11. Early arrhythmia recurrence after cryoballoon ablation in atrial fibrillation: A systematic review and meta‐analysis
  12. Colchicine in Cardiovascular Disease: In-Depth Review
  13. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
  14. Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations
  15. Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
  16. Molecular Insights in Atrial Fibrillation Pathogenesis and Therapeutics: A Narrative Review
  17. Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
  18. Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis
  19. Heroes, politics and media: the unshakable medical practice in the pandemic
  20. Colchicine administered early in acute myocardial infarction: ready, set … go?
  21. Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
  22. Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
  23. The role of cardiology specialties in times of crisis
  24. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
  25. Visually Guided Laser Ablation for Atrial Fibrillation: First experience in Greece
  26. Arteriosclerosis and arterial remodeling; different mechanisms in young adults
  27. Usefulness of a Structured Adult Education Program in Modifying Markers of Cardiovascular Risk After Acute Myocardial Infarction
  28. “TAVI: Valve in valve. A new field for structuralists? Literature review”
  29. Are Drugs Always the Proper Solution to Therapeutic Dilemmas? Non-drug Approaches to the Post-traumatic Stress “Waking Corpse” Syndrome
  30. The Role of Calcium Handling Mechanisms in Reperfusion Injury
  31. The Role of Colchicine in Treating Postoperative and Post–Catheter Ablation Atrial Fibrillation
  32. Colchicum Genus in the Writings of Ancient Greek and Byzantine Physicians
  33. Invasive treatment in peripheral artery disease
  34. Ambulatory Pulse Wave Velocity Monitoring
  35. Permanent pacemaker implantation in octogenarians with unexplained syncope and positive electrophysiologic testing
  36. Remote Ischemic Conditioning and Renal Protection
  37. Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
  38. Peri-procedural Anticoagulation in Catheter Ablation for Atrial Fibrillation: A Review
  39. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  40. Genetics in the Clinical Decision of Antiplatelet Treatment
  41. Editorial: Antiplatelet and Anticoagulation Treatment in Special Populations
  42. In Vivo Assessment of Atherosclerotic Plaque Neovascularization by Contrast-Enhanced Ultrasound: An Unsolved Mystery?
  43. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  44. Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence
  45. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  46. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  47. Assessment of the vulnerable carotid atherosclerotic plaque using contrast-enhanced ultrasonography
  48. Circulating Erythrocyte Microparticles and the Biochemical Extent of Myocardial Injury in ST Elevation Myocardial Infarction
  49. Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals
  50. Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
  51. Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
  52. Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
  53. Jean-Baptiste de Senac's (1693-1770) Important Work on Cardiology and Valvular Disorders
  54. A Preliminary Study on In-Vivo 3-D Imaging of Bioprosthetic Aortic Valve Deformation
  55. Central Blood Pressure Measurement
  56. Essential hypertension in the pathogenesis of age-related macular degeneration
  57. Novel Inflammatory Indices in Aortic Disease
  58. An alternative method of percutaneous mitral valvuloplasty. Matching electrophysiology with interventional cardiology techniques
  59. Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience
  60. Percutaneous Closure of a Large Ascending Aorta Pseudoaneurysm Due to Mediastinitis Using an Amplatzer Occluder Device
  61. Vascular Sealing Implications in Transfemoral Transcatheter Aortic Valve Implantation
  62. Residual platelet reactivity after clopidogrel loading in ST-elevation myocardial infarction patients undergoing a delayed catheterization. Impact on long term clinical events
  63. Implicaciones del sellado vascular en el implante percutáneo transfemoral de válvula aórtica
  64. Percutaneous paravalvular leak closure after TAVI: A demanding approach
  65. Cardiac echo-lab productivity in times of economic austerity
  66. Effect of supine versus sitting position on noninvasive assessment of aortic pressure waveform: a randomized cross-over study
  67. Impact of inflammatory process on left ventricular recovery after Transcatheter Aortic Valve Implantation
  68. Non-invasive 24hour ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: The first feasibility and reproducibility study
  69. Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy
  70. Troponin levels after TAVI are related to the development of distinct electrocardiographic changes
  71. MicroRNAs in Aortic Disease
  72. Quantitative analysis of carotid plaque vasa vasorum by CEUS and correlation with histology after endarterectomy
  73. Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?
  74. Assessment of Left Atrial Function after Percutaneous Closure of Patent Foramen Ovale
  75. CoreValve deployment during cardiopulmonary resuscitation without angiographic injections guidance
  76. Feasibility and Reproducibility of Noninvasive 24-h Ambulatory Aortic Blood Pressure Monitoring With a Brachial Cuff-Based Oscillometric Device
  77. Effect of transcatheter aortic valve implantation on the ascending aorta’s elasticity
  78. Biomarkers as a Guide of Medical Treatment in Cardiovascular Diseases
  79. Residual Platelet Reactivity After Clopidogrel Loading in Patients With ST-Elevation Myocardial Infarction Undergoing an Unexpectedly Delayed Primary Percutaneous Coronary Intervention
  80. Trans-catheter aortic-valve implantation by the subclavian approach complicated with vessel dissection and transient left-arm paralysis
  81. “Bail out” procedures for malpositioning of aortic valve prosthesis (CoreValve)
  82. A 53-Year-Old Woman With Recurrent Transient Ischemic Attacks
  83. Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access
  84. CoreValve Aortic Bioprosthesis